All News

News

Avidin participated in cystic fibrosis consortium meeting

[image type="thumbnail" src="1297" alt="" href="" title="" info_content="" lightbox_caption="" id="" class="" style=""] [text_output]Horizon 2020 Consortium meeting was held on Novel therapeutic approaches for the treatment of

Strategic Changes in the Pipeline

Today Avidin anounced that the company has made extensive recostruction of its projects. The R&D pipeline has changed and become updated accordingly (http://avidinbiotech.com/pipeline/). Q134R, Avidin’s

Approval to a Phase 1 Clinical Study

Approval to Initiate a Phase 1, First–In-Man, Clinical Study for Q134R Soneas Research Ltd. in collaboration with Avidin received approval to initiate a Phase 1,